Developers anxious to get COVID-19 diagnostics to the public face a range of practical challenges. That was the feedback from diagnostics developers participating in a recent conference call conducted by the US Food and Drug Administration.
The 6 March town hall offered technical advice to labs that are developing molecular diagnostics to detect COVID-19, including tips...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?